Abbott Laboratories (ABT) Stock Insights
ABT$102.67-0.43 -0.42%
$177.66B
Market Cap
38.84
P/E
18.60
Forward P/E
47
Score
Abbott Laboratories (ABT) Stock Insights
ABT price $102.67 -0.43 -0.42%
- Ticker
- ABT
- Price
- $102.67
- Change
- -0.43 -0.42%
- Market cap ?
- $177.66B
- P/E ?
- 38.84
- Forward P/E ?
- 18.60
- Dividend yield ?
- 2.40%
- Beta ?
- 0.58
- Sector
- Healthcare
- Industry
- Medical - Devices
- Stocklytics score
- 47
- Value
- 48
- Quality
- 53
- Growth
- 40
Stocklytics score rationale: value 48, quality 53, growth 40.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 20853000000 | 27390000000 | 30578000000 | 31904000000 | 34608000000 | 43075000000 | 43653000000 | 40109000000 | 41950000000 | 44328000000 |
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products…
Fair value
ABT fair value $161.37. Price $102.67. Price is 36% below fair value.
Below fair value, around its usual discount.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 8.72B. Growth 10.22%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 1.73B. Net debt 6.54B. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2027-01-28 | — | 1.64 | — | 13.22B |
| 2026-10-21 | 1.42 | 1.42 | 13.01B | 12.99B |
| 2026-07-16 | 1.31 | 1.28 | 12.59B | 12.52B |
| 2026-04-16 | 1.15 | 1.14 | 11.16B | 11.00B |
| 2026-01-22 | 1.50 | 1.50 | 11.46B | 11.80B |
| 2025-10-15 | 1.30 | 1.30 | 11.37B | 11.39B |
| 2025-07-17 | 1.26 | 1.26 | 11.14B | 11.09B |
| 2025-04-16 | 1.09 | 1.07 | 10.36B | 10.41B |
| 2025-01-22 | 1.34 | 1.34 | 10.97B | 11.03B |
| 2024-10-16 | 1.21 | 1.20 | 10.63B | 10.55B |
| 2024-07-18 | 1.14 | 1.10 | 10.38B | 10.37B |
| 2024-04-17 | 0.98 | 0.95 | 9.96B | 9.88B |
| 2024-01-24 | 1.19 | 1.19 | 10.24B | 10.18B |
| 2023-10-18 | 1.14 | 1.10 | 10.14B | 9.61B |
| 2023-07-20 | 1.08 | 1.04 | 9.98B | 9.70B |
| 2023-04-19 | 1.03 | 0.98 | 9.75B | 9.64B |
| 2023-01-25 | 1.03 | 0.90 | 10.09B | 9.66B |
| 2022-10-19 | 1.15 | 0.91 | 10.41B | 9.65B |
| 2022-07-20 | 1.43 | 1.13 | 11.26B | 10.33B |
| 2022-04-20 | 1.73 | 1.47 | 11.89B | 11.00B |
| 2022-01-26 | 1.32 | 1.21 | 11.47B | 11.09B |
| 2021-10-20 | 1.40 | 0.95 | 10.93B | 9.44B |
| 2021-07-22 | 1.17 | 1.01 | 10.22B | 9.45B |
| 2021-04-20 | 1.32 | 1.33 | 10.46B | 10.75B |
| 2021-01-27 | 1.45 | 1.35 | 10.70B | 9.91B |
| 2020-10-21 | 0.98 | 0.90 | 8.85B | 8.22B |
| 2020-07-16 | 0.57 | 0.43 | 7.33B | 5.40B |
| 2020-04-16 | 0.65 | 0.55 | 7.73B | 6.89B |
| 2020-01-22 | 0.95 | 0.95 | 8.31B | 8.31B |
| 2019-10-16 | 0.84 | 0.84 | 8.08B | 8.08B |
| 2019-07-17 | 0.82 | 0.80 | 7.98B | 7.78B |
| 2019-04-17 | 0.63 | 0.61 | 7.54B | 7.30B |
| 2019-01-23 | 0.81 | 0.81 | 7.76B | 7.76B |
| 2018-10-17 | 0.75 | 0.74 | 7.66B | 7.66B |
| 2018-07-18 | 0.73 | 0.71 | 7.77B | 7.55B |
| 2018-04-18 | 0.59 | 0.58 | 7.39B | 7.26B |
| 2018-01-24 | 0.74 | 0.73 | 7.59B | 7.49B |
| 2017-10-18 | 0.66 | 0.65 | 6.83B | 6.73B |
| 2017-07-20 | 0.62 | 0.60 | 6.64B | 6.53B |
| 2017-04-19 | 0.48 | 0.43 | 6.33B | 5.68B |
Dividends
Yield 2.45%. Payout ratio 90.64%. Frequency Quarterly.
Safety score 75/100 · Safe. Payout ratio is 91% of earnings. Dividends use a moderate share of free cash flow. Dividends were paid in 44 separate years. Yield is 2.5%, in a range that is usually sustainable.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| 2026-10-15 | $0.63 | 2026-10-15 | 2026-11-16 | Quarterly |
| 2026-07-15 | $0.63 | 2026-07-15 | 2026-08-17 | Quarterly |
| 2026-04-15 | $0.63 | 2026-04-15 | 2026-05-15 | Quarterly |
| 2026-01-15 | $0.63 | 2026-01-15 | 2026-02-13 | Quarterly |
| 2025-10-15 | $0.59 | 2025-10-15 | 2025-11-17 | Quarterly |
| 2025-07-15 | $0.59 | 2025-07-15 | 2025-08-15 | Quarterly |
| 2025-04-15 | $0.59 | 2025-04-15 | 2025-05-15 | Quarterly |
| 2025-01-15 | $0.59 | 2025-01-15 | 2025-02-14 | Quarterly |
| 2024-10-15 | $0.55 | 2024-10-15 | 2024-11-15 | Quarterly |
| 2024-07-15 | $0.55 | 2024-07-15 | 2024-08-15 | Quarterly |
| 2024-04-12 | $0.55 | 2024-04-15 | 2024-05-15 | Quarterly |
| 2024-01-11 | $0.55 | 2024-01-12 | 2024-02-15 | Quarterly |
| 2023-10-12 | $0.51 | 2023-10-13 | 2023-11-15 | Quarterly |
| 2023-07-13 | $0.51 | 2023-07-14 | 2023-08-15 | Quarterly |
| 2023-04-13 | $0.51 | 2023-04-14 | 2023-05-15 | Quarterly |
| 2023-01-12 | $0.51 | 2023-01-13 | 2023-02-15 | Quarterly |
| 2022-10-13 | $0.47 | 2022-10-14 | 2022-11-15 | Quarterly |
| 2022-07-14 | $0.47 | 2022-07-15 | 2022-08-15 | Quarterly |
| 2022-04-13 | $0.47 | 2022-04-15 | 2022-05-16 | Quarterly |
| 2022-01-13 | $0.47 | 2022-01-14 | 2022-02-15 | Quarterly |
| 2021-10-14 | $0.45 | 2021-10-15 | 2021-11-15 | Quarterly |
| 2021-07-14 | $0.45 | 2021-07-15 | 2021-08-16 | Quarterly |
| 2021-04-14 | $0.45 | 2021-04-15 | 2021-05-17 | Quarterly |
| 2021-01-14 | $0.45 | 2021-01-15 | 2021-02-16 | Quarterly |
| 2020-10-14 | $0.36 | 2020-10-15 | 2020-11-16 | Quarterly |
| 2020-07-14 | $0.36 | 2020-07-15 | 2020-08-17 | Quarterly |
| 2020-04-14 | $0.36 | 2020-04-15 | 2020-05-15 | Quarterly |
| 2020-01-14 | $0.36 | 2020-01-15 | 2020-02-14 | Quarterly |
| 2019-10-11 | $0.32 | 2019-10-15 | 2019-11-15 | Quarterly |
| 2019-07-12 | $0.32 | 2019-07-15 | 2019-08-15 | Quarterly |
| 2019-04-12 | $0.32 | 2019-04-15 | 2019-05-15 | Quarterly |
| 2019-01-14 | $0.32 | 2019-01-15 | 2019-02-15 | Quarterly |
| 2018-10-12 | $0.28 | 2018-10-15 | 2018-11-15 | Quarterly |
| 2018-07-12 | $0.28 | 2018-07-13 | 2018-08-15 | Quarterly |
| 2018-04-12 | $0.28 | 2018-04-13 | 2018-05-15 | Quarterly |
| 2018-01-11 | $0.28 | 2018-01-12 | 2018-02-15 | Quarterly |
| 2017-10-12 | $0.27 | 2017-10-13 | 2017-11-15 | Quarterly |
| 2017-07-12 | $0.27 | 2017-07-14 | 2017-08-15 | Quarterly |
| 2017-04-11 | $0.27 | 2017-04-14 | 2017-05-15 | Quarterly |
| 2017-01-11 | $0.27 | 2017-01-13 | 2017-02-15 | Quarterly |
| 2016-10-12 | $0.26 | 2016-10-14 | 2016-11-15 | Quarterly |
| 2016-07-13 | $0.26 | 2016-07-15 | 2016-08-15 | Quarterly |
| 2016-04-13 | $0.26 | 2016-04-15 | 2016-05-16 | Quarterly |
| 2016-01-13 | $0.26 | 2016-01-15 | 2016-02-16 | Quarterly |
| 2015-10-13 | $0.24 | 2015-10-15 | 2015-11-15 | Quarterly |
| 2015-07-13 | $0.24 | 2015-07-15 | 2015-08-15 | Quarterly |
| 2015-04-13 | $0.24 | 2015-04-15 | 2015-05-15 | Quarterly |
| 2015-01-13 | $0.24 | 2015-01-15 | 2015-02-13 | Quarterly |
| 2014-10-10 | $0.22 | 2014-10-15 | 2014-11-15 | Quarterly |
| 2014-07-11 | $0.22 | 2014-07-15 | 2014-08-15 | Quarterly |
| 2014-04-11 | $0.22 | 2014-04-15 | 2014-05-15 | Quarterly |
| 2014-01-13 | $0.22 | 2014-01-15 | 2014-02-15 | Quarterly |
| 2013-10-10 | $0.14 | 2013-10-15 | 2013-11-15 | Quarterly |
| 2013-07-11 | $0.14 | 2013-07-15 | 2013-08-15 | Quarterly |
| 2013-04-11 | $0.14 | 2013-04-15 | 2013-05-15 | Quarterly |
| 2013-01-11 | $0.14 | 2013-01-15 | 2013-02-15 | Quarterly |
| 2012-10-11 | $0.24 | 2012-10-15 | 2012-11-15 | Quarterly |
| 2012-07-11 | $0.24 | 2012-07-13 | 2012-08-15 | Quarterly |
| 2012-04-11 | $0.24 | 2012-04-13 | 2012-05-15 | Quarterly |
| 2012-01-11 | $0.23 | 2012-01-13 | 2012-02-15 | Quarterly |
| 2011-10-12 | $0.23 | 2011-10-14 | 2011-11-15 | Quarterly |
| 2011-07-13 | $0.23 | 2011-07-15 | 2011-08-15 | Quarterly |
| 2011-04-13 | $0.23 | 2011-04-15 | 2011-05-16 | Quarterly |
| 2011-01-12 | $0.21 | 2011-01-14 | 2011-02-15 | Quarterly |
| 2010-10-13 | $0.21 | 2010-10-15 | 2010-11-15 | Quarterly |
| 2010-07-13 | $0.21 | 2010-07-15 | 2010-08-15 | Quarterly |
| 2010-04-13 | $0.21 | 2010-04-15 | 2010-05-15 | Quarterly |
| 2010-01-13 | $0.19 | 2010-01-15 | 2010-02-15 | Quarterly |
| 2009-10-13 | $0.19 | 2009-10-15 | 2009-11-15 | Quarterly |
| 2009-07-13 | $0.19 | 2009-07-15 | 2009-08-15 | Quarterly |
| 2009-04-13 | $0.19 | 2009-04-15 | 2009-05-15 | Quarterly |
| 2009-01-13 | $0.17 | 2009-01-15 | 2009-02-15 | Quarterly |
| 2008-10-10 | $0.17 | 2008-10-15 | 2008-11-15 | Quarterly |
| 2008-07-11 | $0.17 | 2008-07-15 | 2008-08-15 | Quarterly |
| 2008-04-11 | $0.17 | 2008-04-15 | 2008-05-15 | Quarterly |
| 2008-01-11 | $0.16 | 2008-01-15 | 2008-02-15 | Quarterly |
| 2007-10-11 | $0.16 | 2007-10-15 | 2007-11-15 | Quarterly |
| 2007-07-11 | $0.16 | 2007-07-13 | 2007-08-15 | Quarterly |
| 2007-04-11 | $0.16 | 2007-04-13 | 2007-05-15 | Quarterly |
| 2007-01-10 | $0.14 | 2007-01-12 | 2007-02-15 | Quarterly |
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-30 | Stratton John G | Buy | 397 | $98.83 | 39.24K |
| 2026-09-30 | Gonzalez Patricia Paola | Buy | 333 | $98.83 | 32.91K |
| 2026-09-30 | Conroy Kevin T | Buy | 318 | $98.83 | 31.43K |
| 2026-09-30 | Ahuja Nita | Buy | 318 | $98.83 | 31.43K |
| 2026-09-30 | Roman Michael F | Buy | 381 | $98.83 | 37.65K |
| 2026-09-23 | Conroy Kevin T | Sell | 52.51K | $103.99 | 5.46M |
| 2026-09-02 | MCCOY JOHN A. JR. | Sell | 27 | $109.54 | 2.96K |
| 2026-09-01 | MCCOY JOHN A. JR. | Sell | 52 | $110.36 | 5.74K |
| 2026-09-01 | Boudreau Philip P | Sell | 388 | $110.36 | 42.82K |
| 2026-08-25 | Ford Robert B | Buy | 246.96K | $59.94 | 14.80M |
| 2026-08-25 | Ford Robert B | Sell | 218.53K | $115.57 | 25.26M |
| 2026-08-25 | Ford Robert B | Buy | 151.87K | $44.40 | 6.74M |
| 2026-08-25 | Ford Robert B | Sell | 180.30K | $116.19 | 20.95M |
| 2026-08-25 | Ford Robert B | Sell | 151.87K | $44.40 | 6.74M |
| 2026-08-25 | Ford Robert B | Sell | 246.96K | $59.94 | 14.80M |
| 2026-08-12 | Morrone Louis H. | Sell | 12 | $107.99 | 1.30K |
| 2026-08-11 | Morrone Louis H. | Sell | 5.85K | $109.83 | 642.51K |
| 2026-06-30 | Stratton John G | Buy | 432 | $90.74 | 39.20K |
| 2026-06-30 | Roman Michael F | Buy | 416 | $90.74 | 37.75K |
| 2026-06-30 | Gonzalez Patricia Paola | Buy | 363 | $90.74 | 32.94K |
| 2026-06-30 | Conroy Kevin T | Buy | 231 | — | — |
| 2026-06-30 | Ahuja Nita | Buy | 347 | — | — |
| 2026-06-30 | Morrone Louis H. | Sell | 269 | $92.71 | 24.94K |
| 2026-06-27 | Cushman Elizabeth C. | Sell | 560 | $94.12 | 52.71K |
| 2026-05-07 | Stratton John G | Buy | 2.00K | $86.82 | 173.64K |
| 2026-04-28 | Moreland Mary K | Buy | 5.31K | $94.41 | 501.69K |
| 2026-04-27 | STARKS DANIEL J | Buy | 10.00K | $92.65 | 926.54K |
| 2026-04-24 | Conroy Kevin T | Buy | 2.29K | — | — |
| 2026-04-24 | Conroy Kevin T | Other | 0 | — | — |
| 2026-04-24 | Stratton John G | Buy | 2.29K | — | — |
| 2026-04-24 | STARKS DANIEL J | Buy | 2.29K | — | — |
| 2026-04-24 | STARKS DANIEL J | Buy | 7.11K | $91.86 | 652.67K |
| 2026-04-24 | Roman Michael F | Buy | 2.29K | — | — |
| 2026-04-24 | O'Grady Michael | Buy | 2.29K | — | — |
| 2026-04-24 | O'Grady Michael | Buy | 5.93K | $91.86 | 544.64K |
| 2026-04-24 | McKinstry Nancy | Buy | 2.29K | — | — |
| 2026-04-24 | McKinstry Nancy | Buy | 2.31K | $91.86 | 211.74K |
| 2026-04-24 | McDew Darren W | Buy | 2.29K | — | — |
| 2026-04-24 | Kumbier Michelle | Buy | 2.29K | — | — |
| 2026-04-24 | Gonzalez Patricia Paola | Buy | 2.29K | — | — |
| 2026-04-24 | Blount Sally E. | Buy | 2.29K | — | — |
| 2026-04-24 | Babineaux-Fontenot Claire | Buy | 2.29K | — | — |
| 2026-04-24 | Ahuja Nita | Buy | 2.29K | — | — |
| 2026-04-23 | Boudreau Philip P | Buy | 8.91K | $92.04 | 819.98K |
| 2026-04-23 | Boudreau Philip P | Buy | 2.20K | $91.50 | 201.30K |
| 2026-03-31 | Stratton John G | Buy | 382 | — | — |
| 2026-03-31 | Roman Michael F | Buy | 367 | — | — |
| 2026-03-31 | Gonzalez Patricia Paola | Buy | 321 | — | — |
| 2026-03-31 | Alpern Robert J | Buy | 76 | — | — |
| 2026-03-31 | Ahuja Nita | Buy | 102 | — | — |
| 2026-03-23 | ORVILLE JACOB A | Buy | 13.26K | — | — |
| 2026-03-23 | ORVILLE JACOB A | Other | 0 | — | — |
| 2026-03-02 | Shroff Eric | Sell | 709 | $115.58 | 81.95K |
| 2026-03-02 | Salvadori Daniel Gesua Sive | Sell | 885 | $115.58 | 102.29K |
| 2026-03-02 | Morrone Louis H. | Sell | 1.14K | $115.58 | 132.22K |
| 2026-03-02 | Moreland Mary K | Sell | 613 | $115.58 | 70.85K |
| 2026-03-02 | MCCOY JOHN A. JR. | Sell | 585 | $115.58 | 67.61K |
| 2026-03-02 | Cushman Elizabeth C. | Sell | 263 | $115.58 | 30.40K |
| 2026-02-27 | Shroff Eric | Sell | 1.38K | $116.26 | 160.90K |
| 2026-02-27 | Scoggins Christopher J | Sell | 5.00K | $116.26 | 580.95K |
| 2026-02-27 | Salvadori Daniel Gesua Sive | Sell | 6.62K | $116.26 | 769.06K |
| 2026-02-27 | Morrone Louis H. | Sell | 4.04K | $116.26 | 469.69K |
| 2026-02-27 | Moreland Mary K | Sell | 4.63K | $116.26 | 538.28K |
| 2026-02-27 | MCCOY JOHN A. JR. | Sell | 1.14K | $116.26 | 132.77K |
| 2026-02-27 | Ford Robert B | Sell | 30.31K | $116.26 | 3.52M |
| 2026-02-27 | Earnhardt Lisa D | Sell | 8.58K | $116.26 | 997.16K |
| 2026-02-27 | Cushman Elizabeth C. | Sell | 1.42K | $116.26 | 165.21K |
| 2026-02-27 | Boudreau Philip P | Sell | 7.44K | $116.26 | 865.09K |
| 2026-02-24 | Shroff Eric | Buy | 44.82K | $114.60 | 5.14M |
| 2026-02-24 | Shroff Eric | Buy | 10.87K | — | — |
| 2026-02-24 | Scoggins Christopher J | Buy | 18.50K | — | — |
| 2026-02-24 | Scoggins Christopher J | Buy | 76.27K | $114.60 | 8.74M |
| 2026-02-24 | Salvadori Daniel Gesua Sive | Buy | 21.64K | — | — |
| 2026-02-24 | Salvadori Daniel Gesua Sive | Buy | 89.23K | $114.60 | 10.23M |
| 2026-02-24 | Morrone Louis H. | Buy | 15.42K | — | — |
| 2026-02-24 | Morrone Louis H. | Buy | 63.56K | $114.60 | 7.28M |
| 2026-02-24 | Moreland Mary K | Buy | 13.95K | — | — |
| 2026-02-24 | Moreland Mary K | Buy | 57.51K | $114.60 | 6.59M |
| 2026-02-24 | MCCOY JOHN A. JR. | Buy | 5.37K | — | — |
| 2026-02-24 | MCCOY JOHN A. JR. | Buy | 22.15K | $114.60 | 2.54M |
| 2026-02-24 | Ford Robert B | Buy | 344.07K | $114.60 | 39.43M |
| 2026-02-24 | Ford Robert B | Buy | 83.46K | — | — |
| 2026-02-24 | Earnhardt Lisa D | Buy | 111.53K | $114.60 | 12.78M |
| 2026-02-24 | Earnhardt Lisa D | Buy | 27.06K | — | — |
| 2026-02-24 | Cushman Elizabeth C. | Buy | 61.96K | $114.60 | 7.10M |
| 2026-02-24 | Cushman Elizabeth C. | Buy | 15.03K | — | — |
| 2026-02-24 | Boudreau Philip P | Buy | 115.41K | $114.60 | 13.23M |
| 2026-02-24 | Boudreau Philip P | Buy | 28.00K | — | — |
| 2026-02-04 | STARKS DANIEL J | Buy | 5.03K | $108.33 | 545.24K |
| 2026-02-04 | STARKS DANIEL J | Buy | 4.97K | $109.14 | 542.09K |
| 2026-01-23 | Ford Robert B | Buy | 18.80K | $107.13 | 2.01M |
| 2025-12-31 | Stratton John G | Buy | 313 | — | — |
| 2025-12-31 | Roman Michael F | Buy | 301 | — | — |
| 2025-12-31 | Gonzalez Patricia Paola | Buy | 263 | — | — |
| 2025-12-31 | Alpern Robert J | Buy | 62 | — | — |
| 2025-12-12 | Ahuja Nita | Other | 0 | — | — |
| 2025-12-12 | Scoggins Christopher J | Other | 0 | — | — |
| 2025-12-12 | Scoggins Christopher J | Other | 68.58K | $87.72 | 6.02M |
| 2025-12-12 | Scoggins Christopher J | Other | 48.85K | $117.58 | 5.74M |
| 2025-12-12 | Scoggins Christopher J | Other | 63.99K | $124.04 | 7.94M |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 3.08K, holders -130 vs prior quarter. Ownership 82.29%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 152.56M | 6.88M | +4.72% | 13.84B |
| VANGUARD CAPITAL MANAGEMENT LLC | 113.75M | 801.06K | +0.71% | 10.32B |
| STATE STREET CORP | 80.93M | 1.35M | +1.70% | 7.34B |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 59.67M | 14.17M | +31.15% | 5.41B |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 59.67M | 59.67M | New | 5.41B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 49.02M | 1.07M | +2.24% | 4.45B |
| GEODE CAPITAL MANAGEMENT, LLC | 39.22M | 70.54K | +0.18% | 3.54B |
| CAPITAL RESEARCH GLOBAL INVESTORS | 36.91M | -12.87M | -25.85% | 3.35B |
| CAPITAL INTERNATIONAL INVESTORS | 34.65M | -2.84M | -7.58% | 3.15B |
| MORGAN STANLEY | 26.61M | -3.49M | -11.60% | 2.41B |
| NORGES BANK | 23.35M | 23.35M | New | 2.12B |
| PRICE T ROWE ASSOCIATES INC /MD/ | 22.79M | 5.51M | +31.89% | 2.07B |
| FRANKLIN TEMPLETON INC | 18.81M | -1.22M | -6.07% | 1.71B |
| NORTHERN TRUST CORP | 18.27M | -1.12M | -5.78% | 1.66B |
| BANK OF AMERICA CORP /DE/ | 17.67M | -1.61M | -8.34% | 1.60B |
| GOLDMAN SACHS GROUP INC | 16.76M | 2.25M | +15.55% | 1.52B |
| DEUTSCHE BANK AG\ | 16.71M | 2.61M | +18.56% | 1.52B |
| JPMORGAN CHASE & CO | 15.10M | -11.67M | -43.60% | 1.40B |
| WELLS FARGO & COMPANY/MN | 15.18M | -732.02K | -4.60% | 1.38B |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 13.59M | 0 | 0.00% | 1.23B |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 13.36M | -2.14M | -13.81% | 1.22B |
| FMR LLC | 13.42M | 2.58M | +23.77% | 1.22B |
| UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC | 12.84M | -362.99K | -2.75% | 1.16B |
| LEGAL & GENERAL GROUP PLC | 11.93M | -355.57K | -2.89% | 1.08B |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 10.90M | 5.37M | +97.33% | 988.81M |
Insights
- Revenue by product
- Revenue by region
| Period | Value |
|---|---|
| FY2011 | Diagnostic Products: 4126000000.0, Established Pharmaceutical Products: 5413000000.0, Nutritional Products: 6006000000.0, Proprietary Pharmaceutical Products: 17022000000.0, Unallocated Amount to Segment: 2951000000.0, Vascular Products: 3333000000.0 |
| FY2012 | Diagnostic Products: 4292000000.0, Established Pharmaceutical Products: 5121000000.0, Nutritional Products: 6471000000.0, Proprietary Pharmaceutical Products: 18012000000.0, Unallocated Amount to Segment: 2907000000.0, Vascular Products: 3071000000.0 |
| FY2013 | Diagnostic Products: 4545000000.0, Established Pharmaceutical Products: 4974000000.0, Nutritional Products: 6740000000.0, Unallocated Amount to Segment: 2577000000.0, Vascular Products: 3012000000.0 |
| FY2014 | Diagnostic Products: 4721000000.0, Established Pharmaceutical Products: 3118000000.0, Nutritional Products: 6953000000.0, Unallocated Amount to Segment: 2469000000.0, Vascular Products: 2986000000.0 |
| FY2015 | Diagnostic Products: 4646000000.0, Established Pharmaceutical Products: 3720000000.0, Nutritional Products: 6975000000.0, Unallocated Amount to Segment: 2272000000.0, Vascular Products: 2792000000.0 |
| FY2016 | Diagnostic Products: 4813000000.0, Established Pharmaceutical Products: 3859000000.0, Nutritional Products: 6899000000.0, Unallocated Amount to Segment: 2386000000.0, Vascular Products: 2896000000.0 |
| FY2017 | Diagnostic Products: 5616000000.0, Established Pharmaceutical Products: 4287000000.0, Medical Devices: 8911000000.0, Nutritional Products: 6925000000.0, Unallocated Amount to Segment: 1651000000.0 |
| FY2018 | Diagnostic Products: 7495000000.0, Established Pharmaceutical Products: 4422000000.0, Medical Devices: 9437000000.0, Nutritional Products: 7229000000.0, Unallocated Amount to Segment: 1995000000.0 |
| FY2019 | Diagnostic Products: 7713000000.0, Established Pharmaceutical Products: 4486000000.0, Medical Devices: 12239000000.0, Nutritional Products: 7409000000.0, Unallocated Amount to Segment: 57000000.0 |
| FY2020 | Diagnostic Products: 10805000000.0, Established Pharmaceutical Products: 4303000000.0, Medical Devices: 11787000000.0, Nutritional Products: 7647000000.0, Unallocated Amount to Segment: 66000000.0 |
| FY2021 | Diagnostic Products: 15644000000.0, Established Pharmaceutical Products: 4718000000.0, Medical Devices: 14367000000.0, Nutritional Products: 8294000000.0 |
| FY2022 | Diagnostic Products: 16584000000.0, Established Pharmaceutical Products: 4912000000.0, Medical Devices: 14687000000.0, Nutritional Products: 7459000000.0 |
| FY2023 | Diagnostic Products: 9988000000.0, Established Pharmaceutical Products: 5066000000.0, Medical Devices: 16887000000.0, Nutritional Products: 8154000000.0 |
| FY2024 | Diagnostic Products: 9341000000.0, Established Pharmaceutical Products: 5194000000.0, Medical Devices: 18986000000.0, Nutritional Products: 8413000000.0 |
| FY2025 | Diagnostic Products: 8937000000.0, Established Pharmaceutical Products: 5536000000.0, Medical Devices: 21387000000.0, Nutritional Products: 8451000000.0 |
| Period | Value |
|---|---|
| FY2010 | Non-US: 19973000000.0, UNITED STATES: 15194000000.0 |
| FY2011 | Non-US: 22837000000.0, UNITED STATES: 16014000000.0 |
| FY2012 | CANADA: 1253000000.0, D [E]: 1740000000.0, F [R]: 1167000000.0, I [N]: 933000000.0, I [T]: 1127000000.0, N [L]: 1883000000.0, Non-US: 10555000000.0, SPAIN: 942000000.0, UNITED STATES: 16784000000.0 |
| FY2013 | B [R]: 470000000.0, C [H]: 792000000.0, C [N]: 1083000000.0, CANADA: 734000000.0, D [E]: 1070000000.0, F [R]: 680000000.0, I [N]: 922000000.0, I [T]: 726000000.0, N [L]: 960000000.0, Non-US: 5283000000.0, R [U]: 525000000.0, SPAIN: 413000000.0, UNITED STATES: 6269000000.0 |
| FY2014 | B [R]: 508000000.0, C [H]: 707000000.0, C [N]: 1321000000.0, D [E]: 978000000.0, F [R]: 488000000.0, G [B]: 447000000.0, I [N]: 1009000000.0, I [T]: 436000000.0, N [L]: 788000000.0, Non-US: 5166000000.0, R [U]: 536000000.0, SPAIN: 310000000.0, UNITED STATES: 6123000000.0 |
| FY2015 | B [R]: 381000000.0, C [H]: 784000000.0, C [N]: 1796000000.0, D [E]: 1004000000.0, F [R]: 375000000.0, G [B]: 430000000.0, I [N]: 1053000000.0, I [T]: 383000000.0, N [L]: 855000000.0, Non-US: 4880000000.0, R [U]: 483000000.0, UNITED STATES: 6270000000.0 |
| FY2016 | B [R]: 410000000.0, C [H]: 766000000.0, C [N]: 1728000000.0, C [O]: 424000000.0, D [E]: 1044000000.0, G [B]: 377000000.0, I [N]: 1114000000.0, I [T]: 365000000.0, N [L]: 830000000.0, Non-US: 4989000000.0, R [U]: 554000000.0, UNITED STATES: 6486000000.0, V [N]: 434000000.0 |
| FY2017 | B [R]: 541000000.0, C [H]: 841000000.0, C [N]: 2146000000.0, D [E]: 1366000000.0, F [R]: 628000000.0, G [B]: 498000000.0, I [N]: 1237000000.0, I [T]: 507000000.0, N [L]: 929000000.0, Non-US: 5741000000.0, R [U]: 664000000.0, UNITED STATES: 9673000000.0 |
| FY2018 | C [H]: 1005000000.0, C [N]: 2311000000.0, D [E]: 1619000000.0, I [N]: 1333000000.0, N [L]: 930000000.0, Non-US: 11215000000.0, UNITED STATES: 10839000000.0 |
| FY2019 | C [H]: 1068000000.0, C [N]: 2346000000.0, D [E]: 1751000000.0, I [N]: 1397000000.0, N [L]: 975000000.0, Non-US: 11534000000.0, UNITED STATES: 11398000000.0 |
| FY2020 | C [H]: 1140000000.0, C [N]: 1965000000.0, D [E]: 2108000000.0, I [N]: 1323000000.0, N [L]: 1084000000.0, Non-US: 12580000000.0, UNITED STATES: 13022000000.0 |
| FY2021 | C [H]: 1313000000.0, C [N]: 2392000000.0, CANADA: 1385000000.0, D [E]: 2572000000.0, I [N]: 1561000000.0, Non-US: 15515000000.0, UNITED STATES: 16642000000.0 |
| FY2022 | C [H]: 1336000000.0, C [N]: 2133000000.0, CANADA: 1280000000.0, D [E]: 2340000000.0, I [N]: 1649000000.0, Non-US: 14841000000.0, UNITED STATES: 18142000000.0 |
| FY2023 | C [H]: 1638000000.0, C [N]: 2253000000.0, D [E]: 2345000000.0, I [N]: 1750000000.0, N [L]: 1074000000.0, Non-US: 14084000000.0, UNITED STATES: 15452000000.0 |
| FY2024 | C [H]: 1747000000.0, C [N]: 2113000000.0, D [E]: 2539000000.0, I [N]: 1817000000.0, N [L]: 1124000000.0, Non-US: 14846000000.0, UNITED STATES: 16323000000.0 |
| FY2025 | C [H]: 1871000000.0, C [N]: 1907000000.0, D [E]: 2759000000.0, I [N]: 1871000000.0, Non-US: 15979000000.0, UNITED STATES: 17126000000.0 |
Insights · Dividends · Forecast · Financials · Learn